Gastrointestinal Diseases Clinical Trial
Official title:
Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt)and PARIET 20 mg DR Tabs (JANSSEN, EGYPT) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions
This is an open-label, randomized, single dose, two-sequence, two-period crossover study,
separated by 7 days washout interval from the first study drug administration.
In this study, the bioavailability of Rabeprazole from Idiazole 20 milligram (mg) delayed
release (DR) tablets and PARIET 20 mg DR tablets after a single oral dose administration of
each to healthy adults under fasting conditions, will be investigated by determining the 90%
confidence limits for the log-transformed ratio (Test product / Reference product) for the
bioequivalence parameters. The influence of sequence, product and period effect will be
tested by analysis of variance (ANOVA).
In this study a total of 60 subjects plus 1-4 additional subjects will be enrolled and split
into two groups (Group A and B) of 30 each. For each subject, a total of 33 blood draws will
be done and the volume of blood will not exceed 300 milliliters (mL) for the study.
PARIET is a registered trademark of EISAI Co. Limited.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02541357 -
Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery
|
N/A | |
| Active, not recruiting |
NCT02358122 -
Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh
|
N/A | |
| Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
| Enrolling by invitation |
NCT00943345 -
Validation of New Tests for Gastrointestinal (GI) Permeability
|
Phase 0 | |
| Completed |
NCT00612404 -
Symptoms and Endoscopic Results in Consideration of Pretreatment
|
N/A | |
| Completed |
NCT01127711 -
Cohort of Swedish Men
|
N/A | |
| Recruiting |
NCT05712525 -
Gut Recovery In Patients Following Surgery
|
||
| Recruiting |
NCT06094153 -
Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function
|
N/A | |
| Recruiting |
NCT05322486 -
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
|
||
| Completed |
NCT02486146 -
GI Biorepository of Tissue and Bodily Fluids
|
N/A | |
| Completed |
NCT01816607 -
Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
|
||
| Completed |
NCT00247715 -
Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)
|
N/A | |
| Completed |
NCT00035334 -
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06286865 -
Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial
|
N/A | |
| Active, not recruiting |
NCT01037049 -
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
|
Phase 2 | |
| Completed |
NCT03725813 -
Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit
|
N/A | |
| Recruiting |
NCT05640401 -
Holographic Screens as a Replacement of Monitors During GI Endoscopies
|
N/A | |
| Completed |
NCT02865564 -
Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics
|
N/A | |
| Completed |
NCT02651857 -
Exploratory Study of Upper and Lower Endoscopic Fuse System
|
N/A | |
| Active, not recruiting |
NCT01984034 -
Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines
|
N/A |